alexa Percutaneous Coronary Intervention Strategies Andprognosis For Graft Lesions After Coronary Artery Bypassgrafting
ISSN: 2155-9880

Journal of Clinical & Experimental Cardiology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

4th International Conference on Clinical & Experimental Cardiology
April 14-16, 2014 Hilton San Antonio Airport, TX, USA

GAO Jing
Accepted Abstracts: J Clin Exp Cardiolog
DOI: 10.4172/2155-9880.S1.021
Objectives: We aimed to compare prognosis of graft-percutaneous coronaryintervention (PCI) and native vessel (NV)-PCI, drug-eluting stents (DES), and bare-metal stents (BMS) for the treatment of graft lesions after coronary artery bypassgrafting (CABG), and to determine the risk factors for major adverse cardiac events (MACEs). Methods: We retrospectively analyzed 289 patients who underwent PCI after CABG between August 2005 and March 2010. The effects on survival were compared between NV and graft-PCI, DES, and BMS. Additionally, risk factors of MACEs post- PCI for graft lesions were analyzed. Results: MACE-free survival and revascularization-free survival were significantly higher in the NV-PCI group compared with the graft-PCI group. There were 63 cases (29.0%) of MACEs in the DES group and 25 cases (52.1%) in the BMS group. Inpatients undergoing NV-PCI, the DES group had significantly fewer MACEs and less target vessel revascularization (TVR) than the BMS group. In patients undergoing graft-PCI, the DES group showed a tendency for lower MACEs, cardiac death, MI and TVR compared with the BMS group. Diabetes, age >70 years, and graft-PCI were independent risk factors for MACEs in post-PCI patients. Conclusions: NV-PCI has better long-term outcomes than graft-PCI, and should therefore be considered first-line treatment for graft disease after CABG. However, graft-PCI is still a viable option. DES was the first choice for graft-PCI due to itssafety and efficacy, and because it is associated with reduced mortality and MACE rate. Diabetes, older age, and graft-PCI are independent risk factors for MACEs inpost-CABG patients undergoing revascularization
image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

1-702-714-7001Extn: 9037

Business & Management Journals


1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

1-702-714-7001 Extn: 9042

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version